FIELD: chemistry.
SUBSTANCE: this invention refers to new compounds of formula (Ia) and to their pharmaceutically acceptable salts. Compounds of this invention are characterised by CB1 receptor antagonist properties. In formula (Ia) , R1 means phenyl independently mono-, di- or tri-substituted with haloid, (lower)alkoxy, (lower)alkyl, halogenated (lower)alkoxy or di(lower)alkylamino; R2 means phenyl, independently mono-, di- or tri-substituted with haloid, halogenated (lower)alkyl, nitro or cyano; R3 means hydrogen, nitro, amino, -NHSO2-R3a or -NHCO-R3b; R3a means (lower)alkyl, di(lower)alkylamino, benzyl, phenyl or phenyl monosubstituted with (lower)alkyl; R3b means benzyl or phenyl monosubstituted with (lower)alkyl.
EFFECT: application of compounds thereof as therapeutically active substance with CB1 receptor agonist properties and to relevant pharmaceutical composition.
18 cl, 1 dwg, 5 tbl, 70 ex
Title | Year | Author | Number |
---|---|---|---|
NEW THIAZOLE DERIVATIVES | 2004 |
|
RU2361868C2 |
PYRROLEYLTHIAZOLES AND THEIR APPLICATION AS REVERSE AGONISTS OF RECEPTOR CB1 | 2003 |
|
RU2330035C2 |
NOVEL REVERSE AGONISTS OF CB1 RECEPTOR | 2003 |
|
RU2339618C2 |
DERIVATIVES OF PYRIDINE AND PYRIMIDINE, METHODS FOR THEIR PREPARING (VARIANTS), PHARMACEUTICAL COMPOSITION AND USING | 2003 |
|
RU2293731C2 |
DERIVATIVES OF BETA-AMINO ACID NITRILES | 2001 |
|
RU2245871C2 |
HETEROCYCLIC INHIBITORS OF Hh-SYGNAL CASCADE, BASED ON THEM MEDICINAL COMPOSITIONS AND METHOD OF TREATING DISEASES INDUCED BY ABBARANT ACTIVITY OF Hh-SIGNAL SYSTEM | 2007 |
|
RU2364597C1 |
NOVEL BENZODIOXOLS | 2003 |
|
RU2304580C2 |
SACCHARIN DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE ACID OR BASE ADDITIVE SALT, PHARMACEUTICAL COMPOSITION EXHIBITING ACTIVITY OF ELASTASE INHIBITOR | 1992 |
|
RU2114835C1 |
BENZOTHIAZOLE INHIBITORS OF PROTEIN TYROSINE KINASES | 1998 |
|
RU2212407C2 |
FUNGICIDE BASED ON TRIAZOLPYRIMIDINE DERIVATIVES AND METHOD OF WOOD PRESERVATION | 2002 |
|
RU2335128C2 |
Authors
Dates
2009-01-20—Published
2004-06-11—Filed